Yamashita Taro, Kaneko Shuichi
Departments of General Medicine, Kanazawa University Hospital, Kanazawa, Ishikawa, Japan,
J Gastroenterol. 2014 Jul;49(7):1105-10. doi: 10.1007/s00535-014-0951-1. Epub 2014 Mar 20.
Hepatocellular carcinoma (HCC) is one of the world's most aggressive diseases and carries a poor prognosis for patients. Recent evidence suggests that HCC is organized by cancer stem cells (CSCs), which are a subset of cells with stem cell-like features. CSCs are considered a pivotal target for the eradication of cancer, and liver CSCs have been investigated using various stem cell markers. Several hepatic stem/progenitor markers have been shown to be useful for isolating putative CSCs from HCC, although the expression patterns and phenotypic diversity of CSCs purified by these markers remain obscure. Recently, we found that liver CSCs defined by different markers show unique features of tumorigenicity and metastasis, with phenotypes closely associated with committed liver lineages. Furthermore, our data suggest that these distinct CSCs collaborate to orchestrate the tumorigenicity and metastasis of HCC. In this review article, we summarize the recent advances in understanding the pathogenesis and heterogeneity of liver CSCs.
肝细胞癌(HCC)是全球侵袭性最强的疾病之一,患者预后较差。最近的证据表明,HCC是由癌症干细胞(CSC)组成的,CSC是具有干细胞样特征的细胞亚群。CSC被认为是癌症根除的关键靶点,并且已经使用各种干细胞标志物对肝脏CSC进行了研究。尽管通过这些标志物纯化的CSC的表达模式和表型多样性仍不清楚,但几种肝干/祖细胞标志物已被证明可用于从HCC中分离假定的CSC。最近,我们发现由不同标志物定义的肝脏CSC表现出独特的致瘤性和转移特征,其表型与特定的肝谱系密切相关。此外,我们的数据表明,这些不同的CSC协同作用以协调HCC的致瘤性和转移。在这篇综述文章中,我们总结了在理解肝脏CSC的发病机制和异质性方面的最新进展。